LingVo.club
📖+20 XP
🎧+15 XP
+25 XP
A Doctor Brings New Cancer Care to Africa (Level A2) — A man helping another man put on a tie

A Doctor Brings New Cancer Care to AfricaCEFR A2

5 Aug 2026

Adapted from Titilope Fadare, SciDev CC BY 2.0

Photo by Ninthgrid, Unsplash

Level A2 – High beginner / Elementary
3 min
124 words

Dr. Adedayo Joseph is an oncologist working in Nigeria. She is leading a clinical trial called HYPOAfrica. This study tests a special radiation treatment that gives higher doses in fewer visits. The study helps doctors learn if this treatment works well for African patients and busy health systems.

In 2020, Dr. Joseph started the first paediatric radiation program in Nigeria. Because there was no training in Sub-Saharan Africa, she went to Germany and the United States to learn. She then returned to Nigeria and built a team of experts at her hospital.

Dr. Joseph also leads the Dorcas Cancer Foundation. Her foundation helps families with travel and care. This support helped reduce waiting times for treatment from 200 days to around 50 days.

Difficult words

  • oncologista doctor who specializes in treating cancer
  • radiationa type of energy used in medical treatment
  • experta person with high knowledge or skill in something
    experts
  • foundationan organization that gives money or help to people
  • reduceto make something smaller in amount or size

Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.

Discussion questions

  • Why is it important to have specialized cancer treatment in every region?
  • How can foundations help patients and their families during treatment?
  • Would you like to work in healthcare in the future? Why or why not?

Related articles

Aging muscle may help cancer grow (Level A2)
17 Jun 2026

Aging muscle may help cancer grow

Scientists found that older, weaker muscle releases fewer extracellular vesicles and less of a microRNA called miR-7a-5p. Exercise can restore vesicle release and may help reduce cancer risk in older adults. The work suggests new biomarkers and therapies.